BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

727 related articles for article (PubMed ID: 14668538)

  • 1. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of matrix metalloproteinase function.
    Bode W
    Biochem Soc Symp; 2003; (70):1-14. PubMed ID: 14587278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
    Maskos K
    Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into MMP-TIMP interactions.
    Bode W; Fernandez-Catalan C; Grams F; Gomis-Rüth FX; Nagase H; Tschesche H; Maskos K
    Ann N Y Acad Sci; 1999 Jun; 878():73-91. PubMed ID: 10415721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural properties of matrix metalloproteinases.
    Bode W; Fernandez-Catalan C; Tschesche H; Grams F; Nagase H; Maskos K
    Cell Mol Life Sci; 1999 Apr; 55(4):639-52. PubMed ID: 10357232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies on MMPs and TIMPs.
    Bode W; Maskos K
    Methods Mol Biol; 2001; 151():45-77. PubMed ID: 11217319
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
    Batra J; Soares AS; Mehner C; Radisky ES
    PLoS One; 2013; 8(9):e75836. PubMed ID: 24073280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitors of metalloproteinases.
    Murphy G
    Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP-TIMP interaction depends on residue 2 in TIMP-4.
    Stratmann B; Farr M; Tschesche H
    FEBS Lett; 2001 Nov; 507(3):285-7. PubMed ID: 11696356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Activity of Tissue Inhibitors of Metalloproteinase (TIMP)-1 against Surface-Anchored Metalloproteinases by the Replacement of Its C-Terminal Domain: Implications for Anti-Cancer Effects.
    Duan JX; Rapti M; Tsigkou A; Lee MH
    PLoS One; 2015; 10(8):e0136384. PubMed ID: 26308720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue inhibitors of metalloproteinases: evolution, structure and function.
    Brew K; Dinakarpandian D; Nagase H
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):267-83. PubMed ID: 10708863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2004 Nov; 11(22):2911-77. PubMed ID: 15544483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.